Anne-Claire Dupont-Gossart4, Thierry Lecomte5, Thomas Aparicio6, Pascal Artru7, Anne Thirot-Bidault8, Fanny Joubert1, Daniella Fanica1 and Julien Taieb1,2* Abstract Background: FOLFOX second-line treatment seems to be a validated option for patients with pancreatic cancer (PC) progressing aft...
Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial. Cancer Chemother Pharmacol. 2013;71(3):765–75. Article CAS PubMed PubMed Central Google Scholar Stephenson CM, Levin RD, Spector T, ...
In addition, chemotherapies with new potent cytotoxic drugs, such as irinotecan and oxaliplatin [11], and molecule-targeted drugs [12–16] have improved the response rate for metastatic colo- rectal cancer. In the treatment of patients with unresectable liver metastases, conversion therapy has been...